PURPOSE: The neonatal constant region fragment receptor (FcRn) binds and transports IgG. FcRn expression in the upper tracheobronchial airways of the lung is recognized. In this study, we sought to characterize the functional expression of FcRn within alveolar regions of lung tissue. METHODS: FcRn immunohistochemistry was performed on intact rat lung. FcRn expression [Western blot, reverse transcription-polymerase chain reaction (RT-PCR), and immunofluorescence microscopy] and IgG transport functionality were assessed in an in vitro rat alveolar epithelial primary cell culture model. An isolated perfused rat lung model was used to examine IgG transport across pulmonary epithelium from airspace to perfusate. RESULTS: FcRn is expressed in intact alveolar epithelium, substantiated by expression and functionality in an in vitro alveolar epithelial model within which IgG transport was temperature sensitive, concentration dependent, and inhibited by excess unlabeled IgG and, to a disproportionate level, by anti-FcRn antibody. Saturable IgG transport across pulmonary epithelium was evident in an isolated perfused rat lung, inhibitable by competing IgG, and displayed a relatively low maximal net IgG absorptive rate of approximately 80 ng/h. CONCLUSION: Pulmonary epithelium expresses functional FcRn providing an absorption pathway potentially important for highly potent Fcgamma-fusion proteins but unlikely to be of quantitative significance for the systemic delivery of inhaled therapeutic monoclonal IgGs.
PURPOSE: The neonatal constant region fragment receptor (FcRn) binds and transports IgG. FcRn expression in the upper tracheobronchial airways of the lung is recognized. In this study, we sought to characterize the functional expression of FcRn within alveolar regions of lung tissue. METHODS:FcRn immunohistochemistry was performed on intact rat lung. FcRn expression [Western blot, reverse transcription-polymerase chain reaction (RT-PCR), and immunofluorescence microscopy] and IgG transport functionality were assessed in an in vitro rat alveolar epithelial primary cell culture model. An isolated perfused rat lung model was used to examine IgG transport across pulmonary epithelium from airspace to perfusate. RESULTS:FcRn is expressed in intact alveolar epithelium, substantiated by expression and functionality in an in vitro alveolar epithelial model within which IgG transport was temperature sensitive, concentration dependent, and inhibited by excess unlabeled IgG and, to a disproportionate level, by anti-FcRn antibody. Saturable IgG transport across pulmonary epithelium was evident in an isolated perfused rat lung, inhibitable by competing IgG, and displayed a relatively low maximal net IgG absorptive rate of approximately 80 ng/h. CONCLUSION: Pulmonary epithelium expresses functional FcRn providing an absorption pathway potentially important for highly potent Fcgamma-fusion proteins but unlikely to be of quantitative significance for the systemic delivery of inhaled therapeutic monoclonal IgGs.
Authors: R S Blumberg; T Koss; C M Story; D Barisani; J Polischuk; A Lipin; L Pablo; R Green; N E Simister Journal: J Clin Invest Date: 1995-05 Impact factor: 14.808
Authors: Kwang-Jin Kim; Tamer E Fandy; Vincent H L Lee; David K Ann; Zea Borok; Edward D Crandall Journal: Am J Physiol Lung Cell Mol Physiol Date: 2004-05-28 Impact factor: 5.464
Authors: Christopher J Morris; Konrad Beck; Marc A Fox; David Ulaeto; Graeme C Clark; Mark Gumbleton Journal: Antimicrob Agents Chemother Date: 2012-03-19 Impact factor: 5.191
Authors: Jamie Campbell; Josquin Nys; Laura Eghobamien; E Suzanne Cohen; Matthew J Robinson; Matthew A Sleeman Journal: MAbs Date: 2016-08-12 Impact factor: 5.857
Authors: Timothy T Kuo; Kristi Baker; Masaru Yoshida; Shuo-Wang Qiao; Victoria G Aveson; Wayne I Lencer; Richard S Blumberg Journal: J Clin Immunol Date: 2010-10-01 Impact factor: 8.317
Authors: Nancy A Goebl; Clifford M Babbey; Amita Datta-Mannan; Derrick R Witcher; Victor J Wroblewski; Kenneth W Dunn Journal: Mol Biol Cell Date: 2008-10-08 Impact factor: 4.138
Authors: Hyuncheol Kim; Robert N Fariss; Connie Zhang; Shaun B Robinson; Michelle Thill; Karl G Csaky Journal: Invest Ophthalmol Vis Sci Date: 2008-05 Impact factor: 4.799